Clinical practice. Chronic hepatitis C infection. [N Engl J Med. 2011] - PubMed

loading

Review [Therapy of chronic Hepatitis C in 2008]. [MMW Fortschr Med. 2008]
Review [Therapy of chronic Hepatitis C in 2008].
Niederau C, Kaden T. MMW Fortschr Med. 2008 Mar 27; 150(13):31-4.
Outcome of antiviral treatment in patients with chronic genotype 1 HCV hepatitis. A retrospective study in 507 patients. [J Gastrointestin Liver Dis. 2010]
Outcome of antiviral treatment in patients with chronic genotype 1 HCV hepatitis. A retrospective study in 507 patients.
Sporea I, Sirli R, Curescu M, Gheorghe L, Popescu A, Bota S, Iacob S. J Gastrointestin Liver Dis. 2010 Sep; 19(3):261-4.
[Is 24 weeks of peginterferon and ribavirin combination therapy sufficient for the patients with genotype 1 chronic hepatitis C?]. [Korean J Gastroenterol. 2010]
[Is 24 weeks of peginterferon and ribavirin combination therapy sufficient for the patients with genotype 1 chronic hepatitis C?].
Song BC. Korean J Gastroenterol. 2010 Jul; 56(1):59-61.
Review Peginterferon and ribavirin for chronic hepatitis C. [N Engl J Med. 2006]
Review Peginterferon and ribavirin for chronic hepatitis C.
Hoofnagle JH, Seeff LB. N Engl J Med. 2006 Dec 7; 355(23):2444-51.
Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander? [J Gastroenterol Hepatol. 2010]
Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander?
Chu CJ, Lee SD. J Gastroenterol Hepatol. 2010 Feb; 25(2):221-3.

Hepatitis C Virus Pathogen Associated Molecular Pattern (PAMP) Triggers Production of Lambda-Interferons by Human Plasmacytoid Dendritic Cells. [PLoS Pathog. 2013]
Hepatitis C Virus Pathogen Associated Molecular Pattern (PAMP) Triggers Production of Lambda-Interferons by Human Plasmacytoid Dendritic Cells.
Stone AE, Giugliano S, Schnell G, Cheng L, Leahy KF, Golden-Mason L, Gale M Jr, Rosen HR. PLoS Pathog. 2013 Apr; 9(4):e1003316. Epub 2013 Apr 18.
Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection. [BMC Gastroenterol. 2013]
Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection.
Stinton LM, Myers RP, Coffin CS, Fritzler MJ. BMC Gastroenterol. 2013 Mar 19; 13:50. Epub 2013 Mar 19.
Efficacy and safety of rituximab in the treatment of vasculitic leg ulcers associated with hepatitis C virus infection. [Case Rep Rheumatol. 2012]
Efficacy and safety of rituximab in the treatment of vasculitic leg ulcers associated with hepatitis C virus infection.
Bonilla-Abadía F, Echeverri AF, Izquierdo JH, Cañas F, Cañas CA. Case Rep Rheumatol. 2012; 2012:923897. Epub 2012 Dec 16.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Clinical practice. Chronic hepatitis C infection.
Clinical practice. Chronic hepatitis C infection.
N Engl J Med. 2011 Jun 23 ;364(25):2429-38. doi: 10.1056/NEJMcp1006613.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed